4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Virbac SA (VIRP) operates in the Drug Manufacturers - General industry and is headquartered in Carros, France with about 6,442 employees. Its market capitalization is roughly €3 billion. In the fiscal year ended 2025-12-31, VIRP reported €1.5B in revenue and €151M in net income.
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €1.5B | €1.4B | €1.2B | €1.2B | — |
| Gross Profit | €975M | €938M | €810M | €790M | — |
| Operating Income (EBIT) | €230M | €228M | €186M | €184M | — |
| Net Income | €151M | €145M | €121M | €122M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (€12M) | (€11M) | (€11M) | (€11M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €1.9B | €1.8B | €1.5B | €1.3B | — |
| Total Liabilities | €789M | €805M | €546M | €494M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VIRP viewer.
About TickerBase · Data methodology & sources · Privacy · Terms